Post-earnings recap
Reported
Wed, May 6, 2026
EPS actual
$-1.06
EPS est.
$-0.01
EPS surprise
-6966.67%
1-day move
+11.00%
Core Scientific reported a significant loss in EPS, missing expectations by a wide margin. Despite this, the stock rose by 11%, indicating that investors may be reacting positively to other factors not captured in the earnings metrics. The lack of revenue data and management commentary leaves some uncertainty about the company's current performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.06 | N/A | -6966.67% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.
Core Scientific Inc (CORZ) operates in the information technology sector, focusing on application software. The company plays a significant role in the growing fields of cloud computing and artificial intelligence, which are increasingly vital for businesses looking to enhance efficiency and innovation.
Last quarter
In the last quarter, Core Scientific reported an EPS of $0.42, significantly beating estimates. However, the stock experienced a slight decline the following day, indicating mixed investor sentiment.
Management promises and guidance
EPS beat streak
0Q
EPS beat rate
50%
Avg EPS surprise
-2922.33%
Avg 1-day reaction
+3.43%
Overall, expectations for Core Scientific's upcoming earnings are mixed due to the lack of analyst estimates and guidance. Investors are keen to see if the company can maintain its recent momentum.
Bull case
If Core Scientific can report strong revenue growth and improved margins, it could signal a robust recovery and attract more investor interest.
Bear case
Conversely, if the company fails to meet profitability expectations or shows signs of operational challenges, it could lead to a significant sell-off.
The print will turn on these.
Q1
What is the expected EPS for this quarter and how does it compare to previous quarters?
EPS will be a critical indicator of the company's profitability and could significantly influence investor sentiment.
Q2
What specific revenue growth targets has management set for this quarter?
Revenue growth is essential for assessing the company's performance and future prospects, especially in a competitive market.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The market may be underestimating Core Scientific's ability to leverage its software innovations for revenue growth this quarter.
Supporting evidence
Recent operational improvements could lead to better-than-expected margins.
The company's strategic partnerships may yield unexpected revenue streams.
Historical data shows that the company has a strong track record of beating EPS estimates.
Key risk
If revenue growth exceeds 20%, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's results are pivotal as they will indicate whether the company can sustain its growth trajectory amidst market challenges.
Bull confirmed if
A revenue growth rate of at least 15% year-over-year would confirm the bull case.
Bear confirmed if
If EPS falls below $0.10, it would support the bear case.
What the market is pricing for the move.
Implied Move
±N/A
Historical Avg
±4.4%
There is currently no options market data available to gauge investor sentiment.
Options are pricing ±11.5% while CORZ has averaged ±4.4% over the last 8 prints — setup is pricing rich.
ATM IV
1.6%
30d HV
57.3%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$330,642.00
20,000 sh
1 insider
Net
$330,642.00
Net selling
Most Active Insiders· 2 open-market trades
$330,642.00
Net selling
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Core Scientific beats expectations, history suggests the stock could rise by around 1.33%, confirming a positive outlook.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await clearer guidance.
Miss
Should the company miss earnings expectations, history indicates a potential decline of approximately 4.62%, leading to increased investor caution.
The lines on the call that would change the story.
Recent Transactions
Sep 28, 2026 · @ $16.76
10,000 sh
$167,586.00
Oct 5, 2026 · @ $16.31
10,000 sh
$163,056.00
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.